GlassScriptPhysician profile
Ryan Philip Marshall
NPI 1982855334
$1,325.89
in general payments reported to CMS, 2019-2025
18 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $84.20 · 2021: $162 · 2022: $187 · 2023: $371 · 2024: $209 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $704.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $619.49 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $134.47 | 2023-2025 | |
| Organogenesis INC. | $106.13 | 2021-2024 | Puraply |
| Smith+Nephew, INC. | $68.88 | 2019-2024 | Grafix Pl, Stravix, Collagenase Santyl |
| Galderma Laboratories, L.P. | $52.84 | 2022-2023 | |
| Kci USA, INC. | $48.66 | 2019-2020 | |
| Revance Therapeutics, INC. | $41.05 | 2024 | Daxxify |
| Medtronic, INC. | $33.62 | 2022 | |
| Allergan, INC. | $33.40 | 2021 | |
| Acera Surgical, INC. | $28.70 | 2025 | Restrata Wound Matrix |
| Bioventus LLC | $27.39 | 2022 | |
| Convatec INC. | $24.58 | 2022 | |
| Davol INC. | $22.79 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $19.94 | 2023 | Exparel |
| Aroa Biosurgery Incorporated | $18.33 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $17.64 | 2021 | |
| Kerecis Limited | $16.95 | 2022 | |
| Olympus America INC. | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Marshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.